Biotech Consortium India Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.37 Cr
as on 23-10-2024
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -3.17%
(FY 2023)
- Profit 290.09%
(FY 2023)
- Ebitda -4.92%
(FY 2023)
- Net Worth 0.84%
(FY 2023)
- Total Assets -22.59%
(FY 2023)
About Biotech Consortium India
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biotech Consortium India Limited India is Mukesh Gupta as COMPANY SECRETARY. Purnima Sharma, Phadnis Suresh, Ram Asrey, and Five other members serve as directors at the Company.
- CIN/LLPIN
U73100DL1990PLC041486
- Company No.
041486
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Sep 1990
- Date of AGM
03 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biotech Consortium India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnima Sharma  | Managing Director | 21-Nov-2005 | Current |
| Mukesh Gupta | Company Secretary | 10-Dec-2014 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anita Gupta | Nominee Director | 01-Nov-2018 | Current |
| Phadnis Suresh | Nominee Director | 06-Sep-2011 | Current |
| Ram Asrey | Additional Director | 30-Jan-2015 | Current |
| Tilak Sharma | Nominee Director | 30-Mar-2021 | Current |
| Sanjeev Khosla | Nominee Director | 28-Oct-2020 | Current |
| Ranjan Rath | Nominee Director | 28-Sep-2022 | Current |
Financial Performance and Corporate Structure Insights of Biotech Consortium India.
Biotech Consortium India Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.17% decrease. The company also saw a substantial improvement in profitability, with a 290.09% increase in profit. The company's net worth moved up by a moderate rise of 0.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Consortium India?
In 2023, Biotech Consortium India had a promoter holding of 74.49% and a public holding of 25.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotech Consortium India?
Biotech Consortium India has a workforce of 28 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Consortium India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Consortium India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
